| Basics |
Theravance Biopharma, Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics.
|
| IPO Date: |
May 16, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$464.01M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 2.15%
|
| Avg Daily Range (30 D): |
$0.17 | 1.85%
|
| Avg Daily Range (90 D): |
$0.18 | 1.96%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.33M |
| Avg Daily Volume (30 D): |
.21M |
| Avg Daily Volume (90 D): |
.19M |
| Trade Size |
| Avg Trade Size (Sh.): |
95 |
| Avg Trade Size (Sh.) (30 D): |
56 |
| Avg Trade Size (Sh.) (90 D): |
57 |
| Institutional Trades |
| Total Inst.Trades: |
2,017 |
| Avg Inst. Trade: |
$1.4M |
| Avg Inst. Trade (30 D): |
$.66M |
| Avg Inst. Trade (90 D): |
$1.31M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.17M |
| Avg Closing Trade (30 D): |
$.57M |
| Avg Closing Trade (90 D): |
$1.58M |
| Avg Closing Volume: |
74.72K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-1.18
|
$-.27
|
$-.31
|
|
Diluted EPS
|
$-1.18
|
$-.27
|
$-.31
|
|
Revenue
|
$ 65.27M
|
$ 15.39M
|
$ 18.75M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -58.33M
|
$ -13.58M
|
$ -15.53M
|
|
Operating Income / Loss
|
$ -50.18M
|
$ -14.43M
|
$ -9.2M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 56.78M
|
$ 72.82M
|
$ 14.42M
|
|
PE Ratio
|
|
|
|
|
